Form 4: Neumora President Sells Shares for Tax Obligations

Neumora Therapeutics President Joshua Pinto sold 5,967 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Joshua Pinto, President of Neumora Therapeutics, Inc. (NMRA), reported a transaction involving the company's common stock.
• On February 17, 2026, Pinto sold 5,967 shares of common stock at a price of $3.535 per share.
• The sale was conducted to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• Following the transaction, Joshua Pinto directly beneficially owns 57,783 shares of common stock.
• Additionally, 152,167 shares are indirectly beneficially owned by Maple DE Holdings LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine, non-discretionary transaction to cover tax liabilities from vested equity, not a signal of changing insider sentiment or company performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing insider transactions, particularly those related to tax withholding for equity compensation, are routine disclosures in the biotechnology and pharmaceutical sectors. Such sales are generally not indicative of management's sentiment towards the company's future prospects but rather a standard part of executive compensation management.

Related Party Transactions

• 152,167 shares are indirectly beneficially owned by Maple DE Holdings LLC, which may be a related entity.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related sale and not a discretionary divestment.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The transaction is a routine sale of shares by an insider to cover tax obligations associated with the vesting of restricted stock units, not a discretionary sale indicating a change in sentiment. Therefore, it does not provide a basis for a change in investment recommendation.

Keywords

Neumora Therapeutics, NMRA, Joshua Pinto, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units